Hormones and cancer

The doctor says: The risks of hormone therapy have been, and continue to be, a source of concern to some women.

Although hormone therapy (HT) was started for women aged 55 years or more in 89% of subjects, who were largely without menopausal symptoms, in the Women’s Health Initiative (WHI) trial reported in 2002, its findings were directly generalised to younger populations of women or to individual women.